CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
STRYKER SUSTAINABILITY SOLUTIONS PULSE OXIMETERSdevice
Likely dose
Reprocessed noninvasive pulse oximeter sensorsAI-extracted
Key inclusion· 3
  • Good general health with no evidence of pre-existing medical problems
  • Fluent in both written and spoken English
  • Able to review informed consent and willing to comply with study procedures
Key exclusion· 12
  • Obesity (BMI >30)
  • History of heart disease, lung disease, kidney disease, or liver disease
  • Prior asthma, sleep apnea, or current CPAP use
  • Diabetes

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05264116
NCT05264116N/ACompleted

SpO2 Accuracy of Noninvasive Disposable Pulse Oximeter Sensor With Motion Conditions

Stryker Sustainability Solutions·interventional·Posted Mar 3, 2022·Updated May 20, 2025

In Brief

A clinical study evaluating STRYKER SUSTAINABILITY SOLUTIONS PULSE OXIMETERS for Healthy and Hypoxia. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this clinical study is to validate the SpO2 accuracy of the Stryker Sustainability Solutions pulse oximetry sensors during motion conditions over the range of 70-100% SaO2 as compared to arterial blood samples assessed by CO-Oximetry. The end goal is to provide supporting documentation for the SpO2 accuracy validation of the reprocessed sensors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Hypoxia
CountriesUnited States

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMar 3, 2022
Enrollment StartFeb 2, 2022
Primary CompletionFeb 3, 2022
TodayJul 2, 2026
Enrollment to primary: 1 daysPosted 4.3 years ago

Interventions

STRYKER SUSTAINABILITY SOLUTIONS PULSE OXIMETERSdevice

Reprocessed noninvasive pulse oximeter sensors.